spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Datwyler to Double Capacity at its Indian Facility

Datwyler



Altdorf, Switzerland and Pune, India, 26 July 2022 — Datwyler, a leading manufacturer of system-critical elastomer components for pharmaceutical packaging, will nearly double capacity at its production operation in Pune, India, and add 400 jobs in the near future. By starting up a second plant on the premises in the third quarter 2022, Datwyler will increase output significantly to meet growing global demand.


For some time now, Datwyler has been operating all three production standards at its Indian site: Essential, Advanced and FirstLine®. Examples for the FirstLine® Standard are OmniFlex® stoppers for use in vials for global distribution. FirstLine® is the most advanced manufacturing concept in the industry that is specially designed to manufacture pharmaceutical rubber components for the high-end pharmaceutical and biotech markets. It is designed to meet the highest bar for quality assurance in the production of critical components for pharmaceutical packaging. The operation encompasses ultra-modern cleanroom technology, automated production cells, automated camera inspection, and a unique validated washing process.

“We are excited to start up the second plant at our Pune site in these days and proud to significantly expand our capacity,” said Dirk Borghs, Head of the Datwyler Healthcare business.

The expansion of the Pune facility originally began in 2019, making the original facility Datwyler Healthcare’s largest production operation by volume. Since then, a whole second plant for Essential and Advanced production standard has been added to the campus. This will enable Datwyler to continuously relocate Essential and Advanced production units from the first plant to the new second plant. As a result, there will be free space in the first plant, which will make it possible to expand production capacity for the FirstLine® standard.

“The impetus for the expansion at the Pune facility comes from the demand generated for critical pharmaceutical packaging components as the injectables market grows rapidly,” said Rahul Dev, Datwyler Senior VP of Global Operations Healthcare Solutions.

The entire facility incorporates rational and lean production flows in accordance with the Six Sigma methodology. The FirstLine® standard is used to produce Datwyler’s most complex elastomer components. Furthermore, Datwyler’s highly specialized fluoropolymer spray coated components are manufactured exclusively with this standard and FirstLine® is characterized by numerous components to guarantee the highest level of quality and safety.
phone +41 41 875 11 23
email info@datwyler.com
web https://datwyler.com/
email Militärstrasse 7 CH-6467 Schattdorf
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Pioneering a New Era of Cell Therapy Manufacturing

Aug 09 2022: Following its successful inspection, our Memphis cell therapy manufacturing facility is paving the way in the cell and gene therapy industry as the first contract development and manufacturing organization (CDMO) in North America to be awarded a commercial GMP license to produce allogeneic cell therapy drug products from the European Medicines Agency (EMA).
More info >>


White Papers

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement